<SEC-DOCUMENT>0001193125-12-203682.txt : 20120502
<SEC-HEADER>0001193125-12-203682.hdr.sgml : 20120502
<ACCEPTANCE-DATETIME>20120502130325
ACCESSION NUMBER:		0001193125-12-203682
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20120502
FILED AS OF DATE:		20120502
DATE AS OF CHANGE:		20120502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theratechnologies Inc.
		CENTRAL INDEX KEY:			0001512717
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A8
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35203
		FILM NUMBER:		12803869

	BUSINESS ADDRESS:	
		STREET 1:		2310 ALFRED-NOBEL BLVD.
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H4S 2B4
		BUSINESS PHONE:		514-336-7800

	MAIL ADDRESS:	
		STREET 1:		2310 ALFRED-NOBEL BLVD.
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H4S 2B4
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d345669d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C.&nbsp;20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 6-K
</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Report of Foreign Private Issuer </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Rule 13a-16 or 15d-16 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>under the Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>May&nbsp;2, 2012 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Commission File Number 001-35203 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>THERATECHNOLOGIES INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Translation of registrant&#146;s name into English) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2310
Alfred-Nobel Boulevard </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Montr&eacute;al, Qu&eacute;bec, Canada </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H4S 2B4 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form 20-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual
report to security holders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a
Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the
registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been
distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If &#147;Yes&#148; is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </FONT></P> <P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THERATECHNOLOGIES INC. </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated May 2, 2012.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">THERATECHNOLOGIES INC.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Jocelyn Lafond</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Jocelyn Lafond</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: Vice President, Legal Affairs,</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">and&nbsp;Corporate Secretary</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: May&nbsp;2, 2012 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d345669dex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD>
<TITLE>Exhibit 99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Arial Narrow" SIZE="2"><B>EXHIBIT 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g345669g47w06.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px">


<IMG SRC="g345669g07p27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Arial Narrow" SIZE="3"><B>Theratechnologies Annual Meeting of Shareholders: Location Change </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="2"><B>Montreal, Canada &#150; May&nbsp;2, 2012</B> &#150; Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) wishes to notify shareholders that it had to change
the location of its annual meeting of shareholders due to ongoing renovations at the Omni Mont-Royal Hotel. The date and time of the meeting remain unchanged. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Arial Narrow" SIZE="2">Theratechnologies&#146; 2012 annual meeting of shareholders will now be held at the <B>Loews Vogue Hotel, 1425 rue de la Montagne</B>, Montreal, Quebec, on Wednesday, May&nbsp;16, 2012, at 10:00 a.m., local
time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="2"><B>About Theratechnologies </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="2">Theratechnologies (TSX: TH) (NASDAQ: THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with
an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company&#146;s website at <U>www.theratech.com</U>. Additional information, including the Annual Information Form and the Annual
Report, is also available on SEDAR at <U>www.sedar.com</U> and on the Securities and Exchange Commission&#146;s website at <U>www.sec.gov</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Arial Narrow" SIZE="2">-30- </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="2"><B>Contact: </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Arial Narrow" SIZE="2">Roch Landriault </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="2">NATIONAL Public Relations </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Arial Narrow" SIZE="2">Phone: 514-843-2345 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="1"><B>Theratechnologies Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Arial Narrow" SIZE="1">2310 Alfred-Nobel Blvd., Montr&eacute;al, Qu&eacute;bec, Canada H4S 2B4 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Arial Narrow" SIZE="1">Phone: 514 336-7800 &#149; Fax:
514 336-7242 &#149; www.theratech.com </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g345669g07p27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g345669g07p27.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1
M````5@````$#!0`!````:`````,#`0`!`````(MW`1!1`0`!`````0```!%1
M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E``"@
MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`#(!7P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/0KKXIZ78?$K_A#;VVD@=BBI>-(
M-A=E#*I';.<9]:[VOGGQ5X77QA\8_%^EQ_+>C3([BS?IME18L#/;.2/QKT7X
M3>.'\6>'6L]1)76],/D7B/PS8X#X]\8/N#ZT`>@UB^+?$4?A/PO>ZY+;M<):
MJK&)6VELL%Z_C6U7"_&/_DE&N_\`7./_`-&+0!T_AW64\0^'=/UB.%H4O(5F
M$;')4'MFM.N5^&?_`"3/PY_UXQ_RKJJ`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@#S;Q)\7(]%\67/AJP\-ZEJVHVZJS+;XP05#9&,G&&':J3?%3Q9&
M/,D^&&L"(<DAV)Q]/+K-T7_DZ37O^P>/_1<->T4`>=>&OC+X=U[4ETN\BNM'
MU)FVK!?)M#-Z!O7V.*]%K@/BSX*L/%'@Z^NC;HNIV,#3VUPHP_RC<4)[@@'C
MUYJ?X1^(;CQ)\.=.N[QS)=0[K:5V.2Y0X!/OC%`'<4444`%%%%`'E?BGQ%K%
ME\=/"^C6VH31Z;=6^Z:W4C:YS)R?R'Y5ZI7C'C/_`)..\'?]>O\`66O9Z`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#QW2#_P`90:Y_V#%_]!AJC\2-
M.O/AWXYM/B)HL1:SN'$6J0+T8GJ3_O>O9@#WJYI?_)T>L_\`8-'_`*!%7K&J
MZ7::UI5UIE_$);6YC,<B'N#Z>_<4`&E:G::UI5KJ5C*);6YC$D;CN#_7M7(_
M&/\`Y)1KO_7./_T8M</\-]4N_AWXXN_AWKDI-I/)YFF3MT);H![-Z=F!'>NY
M^,0)^%&O8_YYQ_\`HQ:`+_PS_P"29^'/^O&/^54_B+X]_P"$.L;:UL+;[;KN
MH/Y5E:CG)Z;F`YQD@8[G\:N?#/\`Y)GX<_Z\8_Y5Y:?$^AC]H/5M4\2:A%;6
MVDP_9K(2AF'F#`.,`^KG\:`.@M_A7XC\11"]\8^,]3%W)\QM+"0)%#G^'T./
M8?B>M9>M^'O&?PJMSKV@^(+K6=(MR&N["^)8JG<CGI[C!'N,UW?_``MWP%_T
M,EM_WQ)_\34-U\5/A[>6<UK-XBM6BFC:-U,;\J1@C[OO0!TOAK7[/Q3X=L]9
ML2?(NH]VTGE&Z,I]P017GOPQUW5H?'?BOPGK>HW%Y+:2^=:O<2%F\O..,]L,
MAJE^SM>F3PUK.GK(9(+6^W1'_99?_L<_C2>-1_PB?QT\,^(Q\EKJJ_8KENV[
M[F3^#(?^`T`>S5XM\9O%&OQZS:Z)X9OI[:>SLI=2O6@<J?+4<`X]@3CW%>T,
MRHI9B`H&23V%>/\`PSM5\9^)O&7BZ\0O:W\C:=;;N\(&#C_@.S]:`/2/"6N)
MXD\)Z7K"$9NK=7<#L^,,/P8$5K331V\$DTK!8XU+NQZ``9)KR;X(74NF+X@\
M%WC'[1H]ZQC![QL2,CVR,_\``JW_`(QZZ="^&NHF-B+B]`LXL'DE_O?^.AJ`
M,CX.ZMK/BB;Q#XCU&^NI+&>[,5E;R.2D2@ECM';@J/P-1^,O$GB'Q'X]7P%X
M4O1IYBB\[4=0`RT:D`X7TX*].23C(P:[/X?^'QX8\"Z3I94++'`'FX_Y:-\S
M?J<?A7F7B:XN_AA\8)_%]Q9S7.@ZQ$(9Y(ADQ-A<CZY0$#N"?2@#7D^"EY&G
MGV7CS7H[\<B:24LI;Z`@_K7H7A6QUC3O#EI:Z]J"ZAJ48(EN%&`W)QV&<#')
MYI=`\5:'XHM1<:-J4%VN,LJ-AT_WE/(_$5L4`%%%%`'B^B_\G2:]_P!@\?\`
MHN&O:*^>]1LO$%_^T9KL/AK5(=-O_LB,9YHA(NSRHLC!!]ORKJKOPO\`&(VS
MB'QOITCXX46RQD_CY?%`'2?%/Q7:>&/!%^))5^VWL+VUK#GYG9AMR!Z#.?\`
M]=+\)_#MQX8^'>FV5XA2ZD#7$R'JA<Y"GW`P#[UYAX"@M;'XD"P^(=I>R^*V
M;=975[/YL+?W=@Z`]<'D9Z8-?0E`'!_$7Q]-X7%GH^BVHOO$>I'9:6^,A!G&
M]A]>@]CV%8$/PDUS7(A=^+/&VK27L@W-#92;(HCZ#L?P`KF]%\6^'T^.'B;7
MO$>I16PL\V=AYJL<8.PD8![*?^^S7I7_``MWP%_T,EM_WQ)_\30!P>LZ9XS^
M$2IK6FZW=:]X>C<"[M+PEFC4G&0><?48P<9!%>Q:)K%IK^B6>K6+[[:ZB$B$
M]1GJ#[@Y!]Q7%ZS\3OA]JNB7^GR^(;5X[FW>(J8WYW*1_=K'_9XOWNOA]<6K
ML2+2^=$]E95;'YD_G0!3\9_\G'>#O^O7^LM>SUXQXS_Y..\'?]>O]9:]&\=Z
MO)H/@76M3A.V:"U?RSZ.?E4_F10!PNL^+?$GCGQ7=>%O`]PEE961VZAK!&=I
MS@JGX@CCDX/(`S3G^"+2)YK^./$+7W7SS-QGUQG/_CU9/PE\9^"/"?@2VMKW
M7+>'4;AWGNU9'+!B<`$@=E`KNO\`A;O@+_H9+;_OB3_XF@#D?#WBGQ+X$\:V
MW@_QG>#4+*^XT_4VZDYP`Q/7G`.>02.2#7L=?/\`\:O&GA3Q+X7L6T768;G4
M[.]62(1JP8*0=QR0.X7\J]TTFZ:^T:QO&^]/;QRGZLH/]:`/-[CX?^-O$]W<
M3>(_&D]E;&1A#9Z4"BA,\$G(YQZ[OK6;JGPK\3>&[234_"'C+5I;R`;_`++=
MR;EF`YP.V?8CGVKU/6?$6C>'K<3ZOJ5M91G[OG2`%OH.I_"N(N?COX$@D*)?
M75QCO#:OC]<4`;'PS\;_`/"<^%5O9XUBU"W<P7<:C`#@9R!V!!S^8[5+\1_&
M0\#^$9M3CC66[D<06L;=&D;."?8`$_A7G?P(U""]\4^-GLMPL9KE9X588(5G
MDQQVXQ76?&CPK?\`BCP2/[,1I;VPG%TD2\F0`$$`=S@Y'TQ0!AV'PL\1>);*
M/4_%?C/5H[ZX42?9K1]B09Y"XZ9'L!^-=)X+\%^)/"FN3BZ\5W&JZ&8<107(
M)D63([G.`!GH><]*@\#?%S0/$UG!:7MRFG:RJA)K:Y.P,XX.QCP>>W7VKT2@
M"IJ>I6FCZ7<ZC?2B*UMHS)(Y[`5Y%IQ\:?%UI-175)_#?A;>4MX[;B>Y`.,E
MAC\\X[`'K5G]H/56M_"VEZ1YWDQZC>`3/Z1IR<^V2I_"N@T[XF_#K2M,M=/M
M/$-JEO;1+%&HC?A5&!_#0!@W7P8U*PB-SX<\;ZU!J"#*_:9BR.?0XQ@?@?I6
MM\,O'FHZY<W_`(:\2Q+!XBTLXEP`!,@.-V!QGIG'!R"*TO\`A;O@+_H9+;_O
MB3_XFO+]7\6Z-+\=])U[PY?1W<<UD\=R8U(!8)(,'('8)^0H`Z'2_P#DZ/6?
M^P:/_0(J]DKQK2_^3H]9_P"P:/\`T"*O9:`/._B[X&;Q9X<%[IRE=:TS,UJR
M<,X')3/KQD>X]ZY>\\:#QQ^S[K<TQ`U.TA2&]3&#O#KAL>C`9^N?2O;*^>/B
MSX=NO!.HZMK.DVY;1?$%LUO?1*/EAF)R&]LL,CW+#O0!Z[\,_P#DF?AS_KQC
M_E7FW@W3=-D^.GC72]7L+6Y>8M<0+<PJ_&X-QD>CC\J](^&?_),_#G_7C'_*
MN0^)WA76K+Q+I_C[PI`UQJ5D`EU:QJ2T\?3(`Y;@E2!SC&.E`'?GP=X8(P?#
MNDD?]><?^%-_X0KPK_T+>D?^`4?^%<]H/QA\(ZO;@7FH)I%\O$UK?GRC&W<;
MCP?Y^PJ_?_%+P1I\#2R^)+"0`9VV\GG,?H$S0!T6G:/IFCI(FF:=:62R$,ZV
M\*QACZG`YK@_CCHC:I\.I[R$?Z3IDJ7<;#J`#AOT.?PKN]'U6WUS1[74[02"
MWN8Q(@D3:P!]1VJ74+*'4M.NK&X&Z&YB:)QZJP(/\Z`/./%WCG_BQJ:W"Y%W
MJEHEO'CKYKC:^/<8?\JZOX?^'AX7\#:5I14+-'"'G]Y&^9OU./PKPGP597^N
M>)M#\!WL#_9O#FH7-W=%@<$*PV@^V[(_X'7TW0!X]XB'_"'?'S1=:7Y++7X?
ML=P>@\P849_'RC^=/\?K_P`)7\7?"GA1?GMK+.HWB]L#D`_@N/\`@=;'QKT.
M35?`$M[:J?MNDRK>Q%1R`O#?H<_\!K(^$+2^*?$7B/QY=0LAO&2TM@P^ZJJN
M['MD+^1H`]=J*YM;>]MI+:Z@CG@D&UXY5#*P]"#UJ6N,'Q3\)1Z[?:->ZFMA
M=VDIB;[6OEH^.ZL>,?7%`')^+?@M9PB36_!,\^CZQ;@RQQ0R$1R$<X'=2?R[
M8KI/A/XUN/&OA#[1?J!J-I*;>Y(&-Y`!#8[9!Y]P:=XB^+'A31M-DDM-6M=3
MO67%O:V,@F:1ST'RY`&?6L[X*>&-0\/^$+BYU6%X+W4KEKEH'7:T:X``(/0]
M3CW%`'I5%%%`'B^B_P#)TFO?]@\?^BX:]HKQ?1?^3I->_P"P>/\`T7#7M%`'
ME/QYT7[1X-@U^V!2_P!(N$ECE4?,$9@#S_O;3^%>B>'M476_#>FZHI'^EVT<
MQQV+*"1^>:K^+M(_M[PAJ^EA<M<VLB(/]O'R_KBN,^!.LC4?AU%8R/\`Z3ID
MSV\B'[RKG<N1^)'_``$T`<M\,=)TR3XE^.M(UC3K.ZG6Z,\0N85D(7S'R1D=
M]Z5ZV?!OAAA@^'=)(_Z\H_\`"O._B)X:USP_XUM/B%X4LWO)U41ZA91J2TJX
MQG`Y((P#CH0#ZUTNA_%[P;K%JKRZM%IMR.);:_/E-&W<9/!_`T`;O_"%>%?^
MA;TC_P``H_\`"M'3]*T[2(6ATVPMK.)FW,EO$L8)]2`.M<UJ/Q5\$:;`TLGB
M*SG('"6K^<S>P"YKJ-.OX=4TVVO[?>(;F)94#KM8`C(R.QH`\A\9_P#)QW@[
M_KU_K+7:_%>UDO/A;X@BB!+"V\S`]%8,?T!KBO&?_)QW@[_KU'\Y:]CG@BNK
M>6WG0/%*A1T/1E(P1^5`'G'PKT7PWK7PUT6ZET73)YQ$8I7>U1F+JQ!R2,D\
M5U[>#/"[?>\.:2?K91_X5Y)HUUJGP1U^^TW4[*[N_!]U+YL%["A<6Y/'S=@<
M8!'?&1FO3;;XE^";J!9H_$^F*I&<2SB-O^^6P:`+O_"$^%2,'PUI'_@%'_A3
M/&&OQ>#?!=_JR0H19P@0Q#A2QPJ+QVR1^%4(/B=X2O==M-'L-46^O+I]BBV0
MNJ\=6;H!3OB;X>N/$_P^U73+-2UTR++"@_C9&#!?QQC\:`.(^'7P]MO$UA%X
MS\9DZOJ6HCS8HK@YBBCS\OR]#QSCH`1Q7K%MI6G6<8CMK"U@0=%BA50/R%>9
M?"_XCZ'!X3M-"UZ]ATC5=+3[-+#?MY.0O`(+8YQ@$=<BMGQ%\4]*@@:Q\+N-
M?UR92+>VL!YRJ?[SLO`4=3S^76@#EO@\`/B5\0@H``O.`/\`KK+7M->%_`VR
MO=(\<>,=.U217U%/*:=@<[FW,6/ORU>H^*_&VC>#!8OK+S10WDAC65(BZQX&
M<MCH.GK0!0\6?"_PMXP\R6^L!#>L/^/RV^23/J>S?B#7">"]1UWX>_$:+P#K
M5\^H:7>1[].N'SE."0!GH/E*E>QQBO1O^%C^"S;?:/\`A*-)V8SC[4N[_OG.
M?TKSK3YY?B9\9M/\0Z=:SKX=T2(JEY)&56X<;ONYZ_,PX[`<XS0`_P"/Z+"_
MA+4IXU>TM[\B8,N5(.QL'ZA&KTU/"7A>1%=/#^D,K#((LX\$?E5?QWX3A\:>
M$KS1I'$<C@/!*1GRY5^Z?IV/L37GW@OXD3>$;:'PM\0+:YTVZM!Y-M?2QL8I
MHUX'S`<XZ;AD$=<4`>D'P7X6)R?#>D9_Z\H_\*D@\(^&K:99H/#^EQ2KG:Z6
MD8(XQP0/2J)^(W@M8_,/BG2<8S@72D_EG-/\.>.M`\6W]Y::+=/=?9%5I)1$
MRQG/920,T`;HLK1;QKQ;6$73#:TPC&\CT+=:GHHH`*CGMX+J%H;B&.:)OO)(
MH93]0:**`%BABMXDBAC2.-!A410`H]`!3Z**`.=\3>']%U&#S[[1]/NIL@>9
M/;([?F15?P[X7\/VJF:WT+3(I0>'CM(U8?B!110!U5%%%`$$5E:0W,ES%:PQ
MSR_ZR58P&?ZGJ:GHHH`:Z+(C(ZAD8896&01Z&F6UK;V<(AM8(H(AR$B0*H_`
M444`2UA^)-$TG5+!WU#2[*[=1\K7%NDA'TR#110!G>$?#NAV*-<VFC:?;S@\
M2PVJ(P_$#-=;110`4444`0+8VB7C7BVL`NF&&F$8WD>A;KV%3T44`%5[:QL[
M-I&M;6"!I3F0Q1A2Y]3CKUHHH`L5S'B?PYH=^HN+S1M.N9BW,DUJCL?Q(S11
M0`OAWPSH%G$)[71--@E!XDBM(U8?B!73444`026-I+=1W4EK`]Q&,),T8+J/
M8]1U-3T44`-=$D1DD571A@JPR"*X75?"'ADZH2?#NDDD@DFRCY_\=HHH`ZS2
M](TW2[<+I^GVEH".1;PK'G\@*T***`.3\8Z!HVH1QW%[I%A<SYQYDULCMCTR
M1FM3PYI&F:5ID8T[3K2SWKE_L\"Q[OKM`S110!HQV5K#<R7,5M"EQ+Q)*L8#
M/]3U-.N+:"[@:"YACFB88:.10RGZ@T44`<''X0\,_P#"1[?^$=TC&[./L4?_
M`,37?111P1+%#&D<:#"HB@`#T`%%%`#ZK7UA9ZC;-!?6D%U">L<\8=?R-%%`
L'$V/@_PQ_:>/^$<TCAC_`,N,?_Q-=U;6MO9PB&U@B@B7HD2!5'X"BB@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g345669g47w06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g345669g47w06.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1
M````5@````$#!0`!````:`````,#`0`!`````(MW`1!1`0`!`````0```!%1
M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E`.^@
MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`$,`V0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/)_%7CCQ'XAUZXN[W4;N(I*WE6Z
MRE%@&3A0!T(Z9Z\5ZIIOQ&\2CX`W^I&>5]0M[P6,=\W+B-@IW$]V&[;GW'>O
M0/$7P6\'^)-5;4IK>XM+B1B\WV24(LK$Y)((/)SU&*W[C0?"WA_P-/I-U;6]
MOX>AA(G24G;MZDD]2Q/.>N<8H`^2?#GC;Q%H?B&#4;74[R68RJ9(WF9Q.,\J
MP)YS7H?QZ\7:W_PEPT**ZGM=/@MXY/*B<IYK,,EFQUQTQ[&M'P-%\'#XTM_L
M$NHM>>:/L8U'B'S,_+MXZYZ;N^.]=A\8X_AZR6;>+GN$U#:1`;'_`(^"F>^>
M-N?[W?..]`'%?!/QQKHLO$-C<2S7\%CISWMN)F+E'7^`$\X;/3VXKR>Z\9>)
M+S63JTNMWWVTOO$JSLNWV4`X`]AQ7T_\)(O`PT&Y_P"$.+OE@+LW/^OSSMW^
MW7&..OO4%U\"?!-UK+:@;:ZC1GWM:13;82?IC('L"*`.H\`ZS=^(?`FCZK?K
MBZN+<&4@8W$$C=CWQG\:Z.HK>WAM+:*VMXDB@B0)'&@P%4#``'I4M`!1110`
M444'I0`FY?4?G1N7^\/SKY#O/A9\0Y+V=TT.\*-(Q4^>G(S_`+U<EK6F:UX=
MU)].U:.>UNT4,T329(!&1T)%`'W3N7^\/SI00>AKXYA^%_Q"N((YHM$O&CD4
M.K>>G((R#]ZO8OAQXETOX=>%5T'QC?C3-6$[S&WF#.VQL;3E01S@]Z`/9**1
M6#H&4Y4C(-+0`4444`%%%%`!1110`4444`%%%%`!7"?%_0-1\1_#J]LM+1I;
ME'2;R5ZRJIR5'J>X'?%=W7,?$#Q<O@GPA=:R(!/,I6."-C@-(QP,^PY)^E`'
MR/X<\)Z[KOB*WTVQL;E;CS5#N8RH@&>68]L=:]$^/OAC6$\8+K8MYKC3I[>.
M-9D4L(V48*MCIGK[Y-1>'_C_`.*(=>A?66MKK3I)`)8DA"&-2>2I'.1[YS7T
M^"&4$<@B@#P#]G;PUJ]GJ&I:W=6\UO82VX@B$BE?.;<#D`]0`.OO]:^@***`
M"BBB@`HKYQ^('QR\0VGBR]TWP^T%K9V,S0%WB$C2LIPQ.[@#(.,5ZG\*O'LG
MCWPS)=7<*0W]K+Y-P(_N.<9#`=L^GJ*`.[HHHH`*^2_CS_R52\_Z]X?_`$`5
M]:5\E_'G_DJEY_U[P_\`H`H`^I="_P"1?TW_`*]8O_0!7S%\?O\`DJ+?]>D/
M]:^G="_Y%_3?^O6+_P!`%?,/[0'_`"4^3_KSA_K0![I>?%CP1HWEVMWK\#3(
MH5E@1I=IQW*`C]:Z#0/%F@^*(6DT75+>\"#+JC8=?JIP1^(KP?P;^S]-K6A0
M:GK>J26+7*"2*WAC#,JGD%B>Y';]:Y3Q9X2U_P"#_BBROK*_+HQ+VEY&NW=C
M&Y'7\1D<@@T`?7E4-5US2M#MQ/JNHVME$>C3RA,_3/6N8;XB6J?"E?&K1+@V
MH<09X,V=FS/IOX^E?..D:-XA^+GB:ZO+[5(8]OS3W5U)M2('.$1?PX`XXY-`
M'TK_`,+2\#?]#-8?]]G_``K4T3QAX>\1W$L&CZM;7LL2;W2)LE5SC->&#]GR
MSQSXXLO_``''_P`<KO?A;\,HO`^JW][%K\.IB>`1%8H@NSYLY)W'TH`]/DD2
M*-I)'5$499F.`!ZDUR\_Q+\%6TS12^)M.WJ<$+,&'YC(KPGXM^-=6\9>,W\)
MZ,TK6,%Q]F2"$X^TS9P2WJ`>`.G&:U+#]FS4)+..2_\`$-O;SD`M%%;F0+[;
MBPS^5`'T-+=V\%J;J:>..W"[C*[!5`]23TKF9/B=X(BD*-XGT[(.#MEW#\QQ
M7SOXQ\2:Y\3O&</AW1VDEL8I/L]E;JVU7V\&5_K@G)Z#\<];;_LTWC0(;GQ+
M!',1\RQVA=0?8EAG\J`/6D^)_@B2143Q+8%F(4`.>2?PKK:^-/%G@T^!?'EE
MH[7PO#^YF\T1;/O-TQD^E?9=`!6%XP\+6?C'PS=:+>NT:3`,DJC)C<'*L/7Z
M=QFMVO/OC5=:E9_##49--:1&9HTG>/[RQ%L-^'0'V)H`\R\*_`VRE\3HM[XJ
MTF_MK60.]K92;I9`#T8?PCUZU]"WNH66F6_GWUW;VL`./,GD"+],FOAK0+K4
M;/Q!83Z2TBWZSIY'E]2^<`>^>F/>O2/V@KK4Y/'T5M=F064=K&UJG\'/WR/?
M=D?@*`/J"UN[:^MUN+2XBN(7^[)$X93]".*FKYU_9MNM2.KZS:!I&TL0+(P/
MW5EW`+CT)&[\AZ5]%4`%%%%`'AWCKX!S:]XEN=7T34K>V6\D,L\%PK85S]XJ
M5!X)YP?SKT7X>^!;7P#X<_LZ&<W%Q*_FW,Y7;O?`'`[``<?_`%ZZRB@`HHHH
M`*^2_CS_`,E4O/\`KWA_]`%?6E?.7Q?^'GBSQ%\0KK4=)T::ZM'AB595=`"0
MN#U(-`'OVA?\B_IO_7K%_P"@"OF+X_?\E1;_`*](?ZU]0:1#);Z+8PRKMDCM
MXT=3V(4`BO!/C%\/_%7B/X@-J&D:/+=6GV:)/,5T`R,Y')!H`^@;4`6<``P!
M&O\`*O&OVD@/^$4T<XY^W'_T`U[/`I2WB5A@A`"/PKR_XY^%]:\4^'=,MM$L
M'O)HKLR.J,HVKL(SR1WH`X465Q>_LK(8`6^SW+3.!_<$QS^6<_A7GW@/P'_P
MG=U<6<&M6=E>1`,D%P&S*O<KCKCN/>OI/X6>';S2?AE;:+KMCY4I,RS6\N&!
M5G;@X)&"#7E'B_X!:WIVI/>^$9!=6I8O'`THCFA]@QP&`['(/\Z`%_X9LUO_
M`*#VG_\`?MZ]+^%'PWO?AZFJK>7]O=_;3$5\E6&W;NSG/^]7B?\`P@_Q>''D
M:W_X,/\`[.O3/@QX?\;:/KNI2^*8]06W>V"Q?:KGS1NW#H-QP<4`>:_#%1)\
M>K8N`Q^UW;<^NR3FOJRZB:>TFB5MK/&R@^A(Q7SU\/\`X>^*](^+\&L7^C2P
M:>L]RQG9T(`9'"G`.>21^=?15`'R1\(=4M?"?Q32/6BMOD2V;/)P(I"<<GMR
MN,^]?6P(8`@@@\@CO7COQ0^"O_"47\FN>'Y8H-2DYN+>7Y4G/]X'^%O7L?;O
MY<OP\^+%BOV:"UU5(H^%6&_`0#VP^*`-3XW_`/)8[+_KA;?^AFOJ"OD:/X8_
M$:ZUBUN]0T:^G9)$W2S7".P4'U+$XKZYH`*R/$^M:7X>\.WNI:S@V,28D0J&
M\S/`0*>I.<8K7KC_`(G>$[GQGX'N]*LI%6[#+-"'.%=E/W2>V1D?7%`'DW@O
MXC?#J'QA$8O!D>CR32;(;[S/,\LG@$J1\@]UZ?2NP^,/C/P?I!MM*US0DUR]
M*^:D!;9Y*GC)?JN<=!Z<]J\<\/?!SQAJ>O0VEYI,]A;+(//N9\!54'G:?XCZ
M8KNOC7\,M?U7Q*NOZ):27\,T*1S0Q<R1LHP#CN"`.G?-`'>?"3Q;X6U_2)[+
MP_I2Z1+;$/-9C!SG^,-_%TQD\_I7HU>*?`OX=ZSX9NK[6];@:TDGA^SPVSGY
M]NX,68#IT``Z]:]KH`****`"BBB@`HHHH`*\HT[QKK`^-&M:5+INJ2Z<%BB5
M"1Y5L!UG([*W7->KUY_J?A?6X/B-/K.GQ076E:S:+9:BCR;)+=1QO3UX[4`0
M#XL_;I9GT#PEKFL6,;F,7MO$!'(1UVYZCWJ]K'Q+AT[4HM)L=!U75=6\A)[B
MTM(@QM@P!`<]CSTKS&#X5:UH:/8/X+MM>2-V\J^CUF2VWH3D9CW@`_0?GUKM
MI-$\8^%_%%]KWAW2;/48=8@@^UV,UR(WMY8TV_*YX9>M`&;XL^(>LVUUX4U'
M^QM9TY9+^:&;2V`$MV`B;>.XRW'T-=AX=^(EMJVH7FF:MIEWH6I6L!N7M[W&
M&A'5U8=0._\`^NL:YT[Q=XDUWPCJNJ:##I[Z;J$SW$:722!8BBA6SGG)R,#T
MJ7QMX5UC6/&']H6-JLEO_8%Y9;S(J_O9%8(N"<\Y'/2@"*/XR69,5_-X>U:#
MP[--Y,>L/&/*SG`8KU"Y[_IVK7\0?$>VTG7#HFF:/J.N:E'&)9XK"/<(5/(W
M'U(P?QK,U+PGK%Q\"$\,16JMJPL883!YB@;U921NSCL>]5/[!\9>$?$=[K'A
MW3+/5H-5M[<75K-<"*2&6--N0QX*]?S]J`*GB_XDG5?AMKLVE?VAHNMZ=+`D
M]O.OESP[I%&?<$9YKKO$?CZT\-W%CID=A?:MK%U%YJ65E'O<(.KMZ#.?RKD+
MCX=>(O%MCXHU'7S::?JNK00P6UK"^](5B8.-[#J25`XSCGZ";^QO'UGK5GXP
MMM)T^;5VLCI]_IK7`"LJME9(WZ#.`2.WOV`.ET'XDZ=JMU>V6I6-[H=_9P&Z
MEM]0383".KJ>X'>L&Z^-$<.FRZM;^$==FT9.5OVC"1N,XW#/8FHCX/\`$7C+
M5K_6/%\-IHT0TN;3[:WMYA*R[P=TCMTP,]/Y=^-\7ZUXKTSX7S^&M1L-&GL8
M88K5=0M=10LZJR[,19W$X49X]30!WMIXZL=*\0>,;_5-0U#[%9)9N+>0*R1F
M2/(6(`Y))ZYQS[5HZ3\1+_4[Z".;P7KMC9RY9KRYC"I&F"=S>G2N/U/X8:SX
MB/BK<D=L+U=/FL))'^61X8MK*P'*CDC]:7PIX1UG1O$-K>'X>P6LD(?-VNNO
M*H)1A_JV<Y!SCGIF@#?T_P"+<VL[9M)\&:Y>V3OM2YC5<$9QDC/%>EU\_P`O
MP_\`$]YJ<%QI/@FU\+WYG1SJ-MJVY8ANR?W0."/8"OH"@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`(;NU@OK.>TNHQ+;S
MQM'*AZ,K#!'Y&N7L?A?X)TV]BO+7P[:+/$P9&8L^TCH<,2,T44`==1110`44
%44`?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
